open access
Telmisartan in hypertensive treatment — practicalities
open access
Abstract
in the treatment of high blood pressure and prevention of
target organ damage. Telmisartan is an angiotensin II receptor
blocker displaying beneficial unique pharmacologic
properties, metabolic effects, antihypertensive efficacy in
monotherapy and combinations and good tolerance. Clinical
studies confirm that telmisartan improves endothelial function,
insulin sensitivity and lipid profiles, reduces arterial stiffness,
left ventricular hypertrophy and the recurrence of atrial
fibrillation. In addition, telmisartan improves renal function
and has potential beneficial effects on prevention of cerebrovascular
disease. The ONTARGET study has shown that
telmisartan provides similar cardiovascular protection
Abstract
in the treatment of high blood pressure and prevention of
target organ damage. Telmisartan is an angiotensin II receptor
blocker displaying beneficial unique pharmacologic
properties, metabolic effects, antihypertensive efficacy in
monotherapy and combinations and good tolerance. Clinical
studies confirm that telmisartan improves endothelial function,
insulin sensitivity and lipid profiles, reduces arterial stiffness,
left ventricular hypertrophy and the recurrence of atrial
fibrillation. In addition, telmisartan improves renal function
and has potential beneficial effects on prevention of cerebrovascular
disease. The ONTARGET study has shown that
telmisartan provides similar cardiovascular protection
Keywords
telmisartan, hypertension, cardiovascular risk, hypertensive treatment
About this articleTitle
Telmisartan in hypertensive treatment — practicalities
Journal
Issue
Article type
Review paper
Pages
169-178
Published online
2012-08-02
Page views
924
Article views/downloads
3100
Bibliographic record
Nadciśnienie tętnicze 2012;16(3):169-178.
Keywords
telmisartan
hypertension
cardiovascular risk
hypertensive treatment
Authors
Krystyna Widecka